TY - JOUR
T1 - Clinical practice guidelines for pancreatic cancer 2016 from the Japan pancreas society a synopsis
AU - Yamaguchi, Koji
AU - Okusaka, Takuji
AU - Shimizu, Kyoko
AU - Furuse, Junji
AU - Ito, Yoshinori
AU - Hanada, Keiji
AU - Shimosegawa, Tooru
AU - Okazaki, Kazuichi
N1 - Publisher Copyright:
© 2017 Wolters Kluwer Health, Inc. All rights reserved.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017
Y1 - 2017
N2 - Objectives: Clinical Practice Guidelines for Pancreatic Cancer based on Evidence-Based Medicine 2006 were first published by the Japan Pancreas Society, and they were revised to Clinical Practice Guidelines for Pancreatic Cancer 2009 in July 2009 and were further revised to Clinical Practice Guidelines for Pancreatic Cancer 2013 in October 2013. These guidelines were established according to evidence-based medicine. In October 2016, the Clinical Practice Guidelines for Pancreatic Cancer were newly revised in Japanese. Methods: In the revised version, we introduced the concepts of GRADE - grading recommendations assessment, development, and evaluation approach for better understanding of the current guidelines. Results: The guidelines show algorithms for the diagnosis, treatment, and chemotherapy of pancreatic cancer and address 7 subjects: diagnosis, surgical therapy, adjuvant therapy, radiation therapy, chemotherapy, stent therapy, and palliative medicine. They include 51 clinical questions and 76 statements. There are statements corresponding to clinical questions, evidence levels, recommended strengths, and agreement rates. Conclusions: These guidelines represent the most standard clinical and practical management at this time in Japan. This is the English synopsis of the Clinical Practice Guidelines for Pancreatic Cancer 2016 in Japanese, which aims to disseminate the Japanese guidelines worldwide for the introduction of Japanese clinical management of these diseases.
AB - Objectives: Clinical Practice Guidelines for Pancreatic Cancer based on Evidence-Based Medicine 2006 were first published by the Japan Pancreas Society, and they were revised to Clinical Practice Guidelines for Pancreatic Cancer 2009 in July 2009 and were further revised to Clinical Practice Guidelines for Pancreatic Cancer 2013 in October 2013. These guidelines were established according to evidence-based medicine. In October 2016, the Clinical Practice Guidelines for Pancreatic Cancer were newly revised in Japanese. Methods: In the revised version, we introduced the concepts of GRADE - grading recommendations assessment, development, and evaluation approach for better understanding of the current guidelines. Results: The guidelines show algorithms for the diagnosis, treatment, and chemotherapy of pancreatic cancer and address 7 subjects: diagnosis, surgical therapy, adjuvant therapy, radiation therapy, chemotherapy, stent therapy, and palliative medicine. They include 51 clinical questions and 76 statements. There are statements corresponding to clinical questions, evidence levels, recommended strengths, and agreement rates. Conclusions: These guidelines represent the most standard clinical and practical management at this time in Japan. This is the English synopsis of the Clinical Practice Guidelines for Pancreatic Cancer 2016 in Japanese, which aims to disseminate the Japanese guidelines worldwide for the introduction of Japanese clinical management of these diseases.
KW - Clinical guidelines
KW - Diagnostic algorithm
KW - GRADE system
KW - Japan pancreas society
KW - Pancreatic cancer
KW - Treatment algorithm
UR - http://www.scopus.com/inward/record.url?scp=85018319340&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85018319340&partnerID=8YFLogxK
U2 - 10.1097/MPA.0000000000000816
DO - 10.1097/MPA.0000000000000816
M3 - Article
C2 - 28426492
AN - SCOPUS:85018319340
VL - 46
SP - 595
EP - 604
JO - Pancreas
JF - Pancreas
SN - 0885-3177
IS - 5
ER -